Benzinga's Top Upgrades, Downgrades For July 26, 2019

Upgrades

• According to JP Morgan, the prior rating for Ambev SA ABEV was changed from Underweight to Neutral. In the second quarter, Ambev showed an EPS of $0.05, compared to $0.04 from the year-ago quarter. Ambev's market cap stands at $81.4 B. The stock has a 52-week-high of $5.44 and a 52-week-low of $3.77. At the end of the last trading period, Ambev closed at $5.17.
• According to Bradesco Corretora, the prior rating for Arcos Dorados Holdings Inc ARCO was changed from Neutral to Outperform. In the first quarter, Arcos Dorados Holdings showed an EPS of $0.06, compared to $0.00 from the year-ago quarter. The current market cap for Arcos Dorados Holdings is at $1.6 B. At the moment, the stock has a 52-week-high of $9.22 and a 52-week-low of $5.92. Arcos Dorados Holdings closed at $7.89 at the end of the last trading period.
• For Bank of America Corporation BAC, Keefe Bruyette & Woods upgraded the previous rating of Market Perform to the current rating Outperform. Bank of America earned $0.74 in the second quarter, compared to $0.63 in the year-ago quarter. The current market cap for Bank of America is at $283.4 B. The current stock performance of Bank of America shows a 52-week-high of $31.91 and a 52-week-low of $22.66. Moreover, at the end of the last trading period, the closing price was at $30.30.
• According to Keefe Bruyette & Woods, the prior rating for Citigroup Inc C was changed from Market Perform to Outperform. For the second quarter, Citigroup had an EPS of $1.83, compared to year-ago quarter EPS of $1.63. The current market cap for Citigroup is at $161.2 B. At the moment, the stock has a 52-week-high of $75.24 and a 52-week-low of $48.42. Citigroup closed at $71.37 at the end of the last trading period.
• For CSX Corp CSX, Atlantic Equities upgraded the previous rating of Underweight to the current rating Neutral. In the second quarter, CSX showed an EPS of $1.08, compared to $1.01 from the year-ago quarter. CSX's market cap stands at $55.4 B. The stock has a 52-week-high of $80.73 and a 52-week-low of $58.47. At the end of the last trading period, CSX closed at $69.50.
• According to Stephens & Co., the prior rating for Franklin Financial Network Inc FSB was changed from Equal-Weight to Overweight. In the second quarter, Franklin Finl Network showed an EPS of $0.34, compared to $0.71 from the year-ago quarter. The current market cap for Franklin Finl Network is at $412.5 M. The stock has a 52-week-high of $41.50 and a 52-week-low of $25.25. At the end of the last trading period, Franklin Finl Network closed at $28.20.
• Keefe Bruyette & Woods upgraded the previous rating for Goldman Sachs Group Inc GS from Market Perform to Outperform. In the second quarter, Goldman Sachs Group showed an EPS of $5.81, compared to $5.98 from the year-ago quarter. Goldman Sachs Group's market cap stands at $80.4 B. The current stock performance of Goldman Sachs Group shows a 52-week-high of $245.08 and a 52-week-low of $151.70. Moreover, at the end of the last trading period, the closing price was at $219.97.
• Argus Research upgraded the previous rating for Hasbro Inc HAS from Hold to Buy. In the second quarter, Hasbro showed an EPS of $0.78, compared to $0.48 from the year-ago quarter. Hasbro's market cap stands at $15.3 B. The current stock performance of Hasbro shows a 52-week-high of $123.63 and a 52-week-low of $76.84. Moreover, at the end of the last trading period, the closing price was at $122.19.
• UBS upgraded the previous rating for Icon PLC ICLR from Sell to Neutral. For the second quarter, Icon had an EPS of $1.69, compared to year-ago quarter EPS of $1.54. Icon's market cap stands at $8.7 B. At the moment, the stock has a 52-week-high of $161.56 and a 52-week-low of $118.10. Icon closed at $161.41 at the end of the last trading period.
• According to Charter Equity, the prior rating for Nokia Oyj NOK was changed from Market Perform to Buy. Nokia earned $0.06 in the second quarter, compared to $0.04 in the year-ago quarter. The current market cap for Nokia is at $31.0 B. The stock has a 52-week-high of $6.65 and a 52-week-low of $4.71. At the end of the last trading period, Nokia closed at $5.70.

Downgrades

• For Abeona Therapeutics Inc ABEO, Mizuho downgraded the previous rating of Buy to the current rating Neutral. In the first quarter, Abeona Therapeutics showed an EPS of ($0.39), compared to ($0.18) from the year-ago quarter. Abeona Therapeutics's market cap stands at $159.7 M. The stock has a 52-week-high of $15.65 and a 52-week-low of $3.24. At the end of the last trading period, Abeona Therapeutics closed at $3.25.
• CIBC downgraded the previous rating for Aphria Inc APHA from Neutral to Underperformer. In the third quarter, Aphria earned ($0.15). The total market value of Aphria's outstanding shares is at $1.4 B. The current stock performance of Aphria shows a 52-week-high of $16.86 and a 52-week-low of $3.75. Moreover, at the end of the last trading period, the closing price was at $5.83.
• RBC Capital downgraded the previous rating for BorgWarner Inc BWA from Outperform to Sector Perform. For the second quarter, BorgWarner had an EPS of $1.00, compared to year-ago quarter EPS of $1.18. BorgWarner's market cap stands at $8.4 B. The current stock performance of BorgWarner shows a 52-week-high of $46.97 and a 52-week-low of $32.46. Moreover, at the end of the last trading period, the closing price was at $40.54.
• According to Barclays, the prior rating for Carbonite Inc CARB was changed from Overweight to Underweight. In the second quarter, Carbonite showed an EPS of $0.56, compared to $0.45 from the year-ago quarter. The total market value of Carbonite's outstanding shares is at $823.2 M. At the moment, the stock has a 52-week-high of $43.62 and a 52-week-low of $21.84. Carbonite closed at $23.90 at the end of the last trading period.
• For Carbonite Inc CARB, Craig-Hallum downgraded the previous rating of Buy to the current rating Hold. In the second quarter, Carbonite showed an EPS of $0.56, compared to $0.45 from the year-ago quarter. Carbonite's market cap stands at $823.2 M. The stock has a 52-week-high of $43.62 and a 52-week-low of $21.84. At the end of the last trading period, Carbonite closed at $23.90.
• For C.H. Robinson Worldwide Inc CHRW, Citigroup downgraded the previous rating of Buy to the current rating Neutral. For the first quarter, C.H. Robinson Worldwide had an EPS of $1.16, compared to year-ago quarter EPS of $1.01. The current market cap for C.H. Robinson Worldwide is at $11.4 B. At the moment, the stock has a 52-week-high of $101.20 and a 52-week-low of $77.72. C.H. Robinson Worldwide closed at $84.07 at the end of the last trading period.
• According to Baird, the prior rating for Camping World Holdings Inc CWH was changed from Outperform to Neutral. For the first quarter, Camping World Holdings had an EPS of ($0.67), compared to year-ago quarter EPS of $0.41. Camping World Holdings's market cap stands at $961.6 M. At the moment, the stock has a 52-week-high of $23.64 and a 52-week-low of $10.12. Camping World Holdings closed at $10.95 at the end of the last trading period.
• According to Bank of America, the prior rating for Dow Inc DOW was changed from Buy to Neutral. In the second quarter, Dow earned $0.86. Dow's market cap stands at $38.0 B. The current stock performance of Dow shows a 52-week-high of $60.52 and a 52-week-low of $46.75. Moreover, at the end of the last trading period, the closing price was at $50.77.
• Baird downgraded the previous rating for DaVita Inc DVA from Outperform to Neutral. DaVita earned $0.91 in the first quarter, compared to $1.05 in the year-ago quarter. The total market value of DaVita's outstanding shares is at $9.4 B. The current stock performance of DaVita shows a 52-week-high of $79.11 and a 52-week-low of $43.40. Moreover, at the end of the last trading period, the closing price was at $58.91.
• According to Janney Capital, the prior rating for Heritage Financial Corp HFWA was changed from Buy to Neutral. In the second quarter, Heritage Financial showed an EPS of $0.43, compared to $0.35 from the year-ago quarter. The total market value of Heritage Financial's outstanding shares is at $1.0 B. The current stock performance of Heritage Financial shows a 52-week-high of $37.40 and a 52-week-low of $27.81. Moreover, at the end of the last trading period, the closing price was at $28.37.
• According to Raymond James, the prior rating for LKQ Corp LKQ was changed from Outperform to Market Perform. For the second quarter, LKQ had an EPS of $0.65, compared to year-ago quarter EPS of $0.61. The total market value of LKQ's outstanding shares is at $8.6 B. At the moment, the stock has a 52-week-high of $36.10 and a 52-week-low of $22.74. LKQ closed at $27.58 at the end of the last trading period.
• For LKQ Corp LKQ, Wellington Shields downgraded the previous rating of Buy to the current rating Gradually Accumulate. For the second quarter, LKQ had an EPS of $0.65, compared to year-ago quarter EPS of $0.61. LKQ's market cap stands at $8.6 B. The current stock performance of LKQ shows a 52-week-high of $36.10 and a 52-week-low of $22.74. Moreover, at the end of the last trading period, the closing price was at $27.58.
• For Masco Corp MAS, KeyBanc downgraded the previous rating of Overweight to the current rating Sector Weight. In the second quarter, Masco showed an EPS of $0.88, compared to $0.75 from the year-ago quarter. The current market cap for Masco is at $12.4 B. The stock has a 52-week-high of $42.58 and a 52-week-low of $27.03. At the end of the last trading period, Masco closed at $42.32.
• For Merit Medical Systems Inc MMSI, Wells Fargo downgraded the previous rating of Outperform to the current rating Market Perform. For the second quarter, Merit Medical Systems had an EPS of $0.42, compared to year-ago quarter EPS of $0.43. The current market cap for Merit Medical Systems is at $3.0 B. At the moment, the stock has a 52-week-high of $66.34 and a 52-week-low of $49.40. Merit Medical Systems closed at $54.84 at the end of the last trading period.
• Needham downgraded the previous rating for Merit Medical Systems Inc MMSI from Buy to Hold. For the second quarter, Merit Medical Systems had an EPS of $0.42, compared to year-ago quarter EPS of $0.43. Merit Medical Systems's market cap stands at $3.0 B. At the moment, the stock has a 52-week-high of $66.34 and a 52-week-low of $49.40. Merit Medical Systems closed at $54.84 at the end of the last trading period.
• For Match Group Inc MTCH, BMO Capital downgraded the previous rating of Outperform to the current rating Market Perform. In the first quarter, Match Group showed an EPS of $0.42, compared to $0.26 from the year-ago quarter. Match Group's market cap stands at $21.8 B. At the moment, the stock has a 52-week-high of $79.30 and a 52-week-low of $33.30. Match Group closed at $77.70 at the end of the last trading period.
• According to Wedbush, the prior rating for NovoCure Ltd NVCR was changed from Outperform to Neutral. For the second quarter, NovoCure had an EPS of ($0.01), compared to year-ago quarter EPS of ($0.17). The total market value of NovoCure's outstanding shares is at $7.3 B. At the moment, the stock has a 52-week-high of $78.42 and a 52-week-low of $26.02. NovoCure closed at $77.08 at the end of the last trading period.
• According to JP Morgan, the prior rating for NovoCure Ltd NVCR was changed from Overweight to Neutral. In the second quarter, NovoCure showed an EPS of ($0.01), compared to ($0.17) from the year-ago quarter. The total market value of NovoCure's outstanding shares is at $7.3 B. At the moment, the stock has a 52-week-high of $78.42 and a 52-week-low of $26.02. NovoCure closed at $77.08 at the end of the last trading period.

Initiations

• With a current rating of Outperform, Raymond James initiated coverage on BridgeBio Pharma Inc BBIO. The price target seems to have been set at $36.00 for BridgeBio Pharma. The current market cap for BridgeBio Pharma is at $3.3 B. The stock has a 52-week-high of $31.64 and a 52-week-low of $24.06. At the end of the last trading period, BridgeBio Pharma closed at $26.79.
• With a current rating of Buy, Canaccord Genuity initiated coverage on CRISPR Therapeutics AG CRSP. The price target seems to have been set at $72.00 for CRISPR Therapeutics. CRISPR Therapeutics earned ($0.93) in the first quarter, compared to ($0.62) in the year-ago quarter. The current market cap for CRISPR Therapeutics is at $2.7 B. The stock has a 52-week-high of $59.00 and a 52-week-low of $22.22. At the end of the last trading period, CRISPR Therapeutics closed at $49.66.
• Baird initiated coverage on Cue Biopharma Inc CUE with an Outperform rating. The price target for Cue Biopharma is set to $13.00. The total market value of Cue Biopharma's outstanding shares is at $142.1 M. At the moment, the stock has a 52-week-high of $11.95 and a 52-week-low of $4.16. Cue Biopharma closed at $6.84 at the end of the last trading period.
• With a current rating of Buy, GMP Securities initiated coverage on GeoPark Ltd GPRK. The price target seems to have been set at $26.00 for GeoPark. GeoPark earned $0.30 in the first quarter, compared to $0.28 in the year-ago quarter. GeoPark's market cap stands at $1.1 B. The current stock performance of GeoPark shows a 52-week-high of $21.74 and a 52-week-low of $10.89. Moreover, at the end of the last trading period, the closing price was at $18.00.
• Baird initiated coverage on Gritstone Oncology Inc GRTS with an Outperform rating. The price target for Gritstone Oncology is set to $17.00. Gritstone Oncology earned ($0.62) in the first quarter. The total market value of Gritstone Oncology's outstanding shares is at $372.1 M. The current stock performance of Gritstone Oncology shows a 52-week-high of $32.90 and a 52-week-low of $8.75. Moreover, at the end of the last trading period, the closing price was at $10.42.
• With a current rating of Outperform, Baird initiated coverage on Neonode Inc NEON. The price target seems to have been set at $15.00 for Neonode. For the first quarter, Neonode had an EPS of ($0.07), compared to year-ago quarter EPS of ($0.01). The total market value of Neonode's outstanding shares is at $24.7 M. The current stock performance of Neonode shows a 52-week-high of $4.75 and a 52-week-low of $1.31. Moreover, at the end of the last trading period, the closing price was at $2.62.
• With a current rating of Outperform, Baird initiated coverage on Neon Therapeutics Inc NTGN. The price target seems to have been set at $15.00 for Neon Therapeutics. Neon Therapeutics earned ($0.76) in the first quarter. Neon Therapeutics's market cap stands at $87.5 M. The current stock performance of Neon Therapeutics shows a 52-week-high of $13.00 and a 52-week-low of $3.06. Moreover, at the end of the last trading period, the closing price was at $3.09.